Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/07/2000 | US6034135 Delivering anionic macromolecule to cell |
03/07/2000 | US6034072 Genetic engineering; anticancer, antitumor agent |
03/07/2000 | US6034063 Human phosphatidylinositol transfer protein gamma |
03/07/2000 | US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein |
03/07/2000 | US6034060 Peptide having an ability to promote the activation of protein C by thrombin |
03/07/2000 | US6033913 Detection of ligand Interaction with polymeric material |
03/07/2000 | US6033910 Antisense inhibition of MAP kinase kinase 6 expression |
03/07/2000 | US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy |
03/07/2000 | US6033905 Gibbon ape leukemia virus-based retroviral vectors |
03/07/2000 | US6033904 Recombinant swinepox virus |
03/07/2000 | US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors |
03/07/2000 | US6033902 Vector comprising a replication competent HIV-1 provirus and a heterologous gene |
03/07/2000 | US6033900 The use of a rhamnogalacturonase for degradation or modification of plant cell materials for increasing digestablility of animal feeds. |
03/07/2000 | US6033898 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
03/07/2000 | US6033895 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
03/07/2000 | US6033894 Kaposi's Syndrome Herpesvirus protease and assembly protein compositions and methods |
03/07/2000 | US6033893 Use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation. |
03/07/2000 | US6033892 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
03/07/2000 | US6033890 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
03/07/2000 | US6033889 The protein is used as a necessary medicament in treatment of inflammation, disease of autoimmunization,or chromosome lesion. |
03/07/2000 | US6033886 Recombinant infectious non-segmented negative strand RNA virus |
03/07/2000 | US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
03/07/2000 | US6033884 Delivering nucleic acid into a cell. |
03/07/2000 | US6033883 Production of polyketides in bacteria and yeast |
03/07/2000 | US6033882 Chiral synthesis of 2-hydroxy carboxylic acids with a dehydrogenase |
03/07/2000 | US6033881 Method for one step isothermal non-transcription based amplification of nucleic acids |
03/07/2000 | US6033880 Nucleic acid amplification reaction apparatus and method |
03/07/2000 | US6033878 Protein-bound magnetic particles and process of producing the same |
03/07/2000 | US6033877 Peptide expression and delivery system |
03/07/2000 | US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin. |
03/07/2000 | US6033875 Method of improved production of insulin-like growth factor |
03/07/2000 | US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects |
03/07/2000 | US6033872 Polynucleotides encoding a novel human 11cb splice variant |
03/07/2000 | US6033870 Human transmembrane protein |
03/07/2000 | US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation. |
03/07/2000 | US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor |
03/07/2000 | US6033863 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids |
03/07/2000 | US6033860 Screening a drug for deleterious side effects on a cell. |
03/07/2000 | US6033856 Promoter of the cdc25B gene, its preparation and use |
03/07/2000 | US6033851 Method for suppressing nonspecific hybridization in primer extension method |
03/07/2000 | US6033850 Electrochemical denaturation of double-stranded nucleic acid |
03/07/2000 | US6033849 Identification of such genes is critical for diagnosis, prognosis, and course of therapy. |
03/07/2000 | US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
03/07/2000 | US6033823 Mutated penicillin G acylase genes |
03/07/2000 | US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus |
03/07/2000 | US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus |
03/07/2000 | CA2190072C Fluorescence polarization detection of nucleic acid amplification |
03/07/2000 | CA2175892C Kinase receptor activation assay |
03/07/2000 | CA1340921C Purified thermostable enzyme |
03/04/2000 | CA2281987A1 Method for supporting dna-fixation and dna-fixed support |
03/02/2000 | WO2000011478A1 Assays, methods and means for modulating nuclear localisation |
03/02/2000 | WO2000011446A2 Signal generating oligonucleotide-based biosensor |
03/02/2000 | WO2000011223A1 Use of pooled probes in genetic analysis |
03/02/2000 | WO2000011222A1 Methods of screening nucleic acids for nucleotide variations |
03/02/2000 | WO2000011221A1 Method for determining polynucleotide sequence variations |
03/02/2000 | WO2000011220A1 Fluorescence polarization in nucleic acid analysis |
03/02/2000 | WO2000011219A1 Subtle mitochondrial mutations as tumor markers |
03/02/2000 | WO2000011217A1 Compounds and methods for enhancing delivery of free polynucleotide |
03/02/2000 | WO2000011216A1 Method of screening for compounds that modulate the activity of a molecular target |
03/02/2000 | WO2000011213A1 Fluorescent probe and method for quantitating inositol triphosphate by using the same |
03/02/2000 | WO2000011212A1 Enzyme activity screen with direct substrate reloading |
03/02/2000 | WO2000011211A1 Enzyme activity screen with substrate replacement |
03/02/2000 | WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
03/02/2000 | WO2000011204A2 Homer interacting proteins |
03/02/2000 | WO2000011202A1 Cationic complexes of polymer-modified adenovirus |
03/02/2000 | WO2000011201A1 Targeted alphavirus and alphaviral vectors |
03/02/2000 | WO2000011200A2 Plant expression vectors |
03/02/2000 | WO2000011199A1 COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT |
03/02/2000 | WO2000011198A1 Reduction of bowman-birk protease inhibitor levels in plants |
03/02/2000 | WO2000011197A1 Nucleic acids having promoter activity and transgenic plants containing the same |
03/02/2000 | WO2000011196A1 Polynucleotide sequences |
03/02/2000 | WO2000011195A1 C-myc is activated by beta-catenin and tcf-4 |
03/02/2000 | WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
03/02/2000 | WO2000011193A1 Novel proteases and dnas encoding the same |
03/02/2000 | WO2000011192A2 Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids |
03/02/2000 | WO2000011191A2 Tpl-2/cot kinase and methods of use |
03/02/2000 | WO2000011190A2 UDP-N-ACETYL GLUCOSAMINYL: β1,4 GALACTOSIDE: β1,3N-ACETYL GLUCOSAMINYL TRANSFERASE (POLYLACTOSAMINYL TYPE) |
03/02/2000 | WO2000011189A1 Use of leu a promoter of stagonospora nodorum in screening method for fungicides |
03/02/2000 | WO2000011188A1 Transgenic microbial polyhydroxyalkanoate producers |
03/02/2000 | WO2000011187A1 Molecular sequence of swine retrovirus and methods of use |
03/02/2000 | WO2000011186A1 Modified hcv peptide vaccines |
03/02/2000 | WO2000011185A2 Improved expression of cry3b insecticidal protein in plants |
03/02/2000 | WO2000011184A1 Staphylococcus aureus polypeptides |
03/02/2000 | WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
03/02/2000 | WO2000011182A1 Basb024 outer membrane protein of neisseria meningitidis |
03/02/2000 | WO2000011181A1 NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA) |
03/02/2000 | WO2000011180A1 NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA) |
03/02/2000 | WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
03/02/2000 | WO2000011178A2 An antifungal protein from tall fescue and its use in plant disease control |
03/02/2000 | WO2000011177A1 Seed-preferred promoters |
03/02/2000 | WO2000011176A2 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
03/02/2000 | WO2000011175A1 Genetic method for the expression of polyproteins in plants |
03/02/2000 | WO2000011174A1 Human il-1 epsilon dna and polypeptides |
03/02/2000 | WO2000011173A1 Leptin-related peptides |
03/02/2000 | WO2000011172A1 Antithrombin nucleotides and proteins from horn fly |
03/02/2000 | WO2000011171A2 Human rna-associated proteins |
03/02/2000 | WO2000011170A1 14400 receptor, a g-protein coupled receptor |
03/02/2000 | WO2000011169A2 Human cell signaling proteins (csig) |
03/02/2000 | WO2000011168A2 Genes that regulate hematopoietic blood forming stem cells and uses thereof |
03/02/2000 | WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |